Published in Arterioscler Thromb Vasc Biol on March 31, 2011
Further evidence for promoting transdermal estrogens in the management of postmenopausal symptoms. Menopause (2011) 1.40
Stroke risk in women: the role of menopause and hormone therapy. Lancet Neurol (2012) 1.10
Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases. J Aging Res (2013) 0.91
High level of plasma estradiol as a new predictor of ischemic arterial disease in older postmenopausal women: the three-city cohort study. J Am Heart Assoc (2012) 0.89
Statins but not aspirin reduce thrombotic risk assessed by thrombin generation in diabetic patients without cardiovascular events: the RATIONAL trial. PLoS One (2012) 0.86
Arachidonate 15-lipoxygenase enzyme products increase platelet aggregation and thrombin generation. PLoS One (2014) 0.84
Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk. Thromb J (2015) 0.84
Thrombin Generation in Acute Ischaemic Stroke. Stroke Res Treat (2016) 0.77
Genetic Determinants of Thrombin Generation and Their Relation to Venous Thrombosis: Results from the GAIT-2 Project. PLoS One (2016) 0.77
Thrombin Generation and Atherothrombosis: What Does the Evidence Indicate? J Am Heart Assoc (2016) 0.76
Postmenopausal Hormone Therapy and Risk of Stroke: Impact of the Route of Estrogen Administration and Type of Progestogen. Stroke (2016) 0.75
Coagulation factor XII genetic variation, ex vivo thrombin generation, and stroke risk in the elderly: results from the Cardiovascular Health Study. J Thromb Haemost (2015) 0.75
A new measure for in vivo thrombin activity in comparison with in vitro thrombin generation potential in patients with hyper- and hypocoagulability. Clin Exp Med (2016) 0.75
Activation of blood coagulation and thrombin generation in acute ischemic stroke treated with rtPA. J Thromb Thrombolysis (2017) 0.75
Low thrombin generation predicts poor prognosis in ischemic stroke patients after thrombolysis. PLoS One (2017) 0.75
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet (2009) 14.86
Mild cognitive impairment. Lancet (2006) 10.21
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol (2011) 5.60
Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med (2005) 4.85
Benzodiazepine use and risk of dementia: prospective population based study. BMJ (2012) 4.32
Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. JAMA (2009) 4.01
Downward trends in the prevalence of childhood overweight in the setting of 12-year school- and community-based programmes. Public Health Nutr (2008) 3.53
Relationship between blood pressure and outdoor temperature in a large sample of elderly individuals: the Three-City study. Arch Intern Med (2009) 3.38
Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation (2007) 3.17
Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ (2006) 2.79
Sleep and depression. J Clin Psychiatry (2005) 2.78
Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening. Prenat Diagn (2004) 2.71
Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol (2012) 2.65
Slow walking speed and cardiovascular death in well functioning older adults: prospective cohort study. BMJ (2009) 2.62
Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clin Infect Dis (2003) 2.54
The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. Brain (2005) 2.51
Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med (2009) 2.41
Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care (2008) 2.32
Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation (2003) 2.26
Antipsychotic use and myocardial infarction in older patients with treated dementia. Arch Intern Med (2012) 2.16
Anxiety and mortality risk in community-dwelling elderly people. Br J Psychiatry (2013) 2.13
Relation of heart rate at rest and long-term (>20 years) death rate in initially healthy middle-aged men. Am J Cardiol (2008) 2.03
The Three-Factor Eating Questionnaire-R18 is able to distinguish among different eating patterns in a general population. J Nutr (2004) 1.95
Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the three-city study. J Am Geriatr Soc (2009) 1.87
Do subject characteristics modify the effects of particulate air pollution on daily mortality among the elderly? J Occup Environ Med (2004) 1.82
Relationship between blood pressure and depression in the elderly. The Three-City Study. J Hypertens (2008) 1.79
Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ (2008) 1.78
Natural history of decline in instrumental activities of daily living performance over the 10 years preceding the clinical diagnosis of dementia: a prospective population-based study. J Am Geriatr Soc (2007) 1.75
Does personality explain social inequalities in mortality? The French GAZEL cohort study. Int J Epidemiol (2008) 1.73
Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study. Arterioscler Thromb Vasc Biol (2009) 1.73
Postnatal weight and height growth velocities at different ages between birth and 5 y and body composition in adolescent boys and girls. Am J Clin Nutr (2008) 1.72
Frailty among community-dwelling elderly people in France: the three-city study. J Gerontol A Biol Sci Med Sci (2008) 1.70
Fish, meat, and risk of dementia: cohort study. BMJ (2002) 1.66
Differential effects of oral and transdermal postmenopausal estrogen replacement therapies on C-reactive protein. Thromb Haemost (2003) 1.66
Neurodegenerative diseases and exposure to pesticides in the elderly. Am J Epidemiol (2003) 1.65
Resilience and mental health. Clin Psychol Rev (2010) 1.64
Excessive heart rate increase during mild mental stress in preparation for exercise predicts sudden death in the general population. Eur Heart J (2009) 1.61
Is there a link between open-angle glaucoma and dementia? The Three-City-Alienor cohort. Ann Neurol (2013) 1.60
Household income is associated with the risk of metabolic syndrome in a sex-specific manner. Diabetes Care (2005) 1.59
Independent contribution of dairy products and calcium intake to blood pressure variations at a population level. J Hypertens (2006) 1.56
Fish consumption is associated with lower heart rates. Circulation (2003) 1.56
Alternative Healthy Eating Index and mortality over 18 y of follow-up: results from the Whitehall II cohort. Am J Clin Nutr (2011) 1.54
Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care (2007) 1.53
Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study. Diabetes Care (2008) 1.52
Association of influenza vaccination with reduced risk of venous thromboembolism. Thromb Haemost (2009) 1.52
Inappropriate medication use and risk of falls--a prospective study in a large community-dwelling elderly cohort. BMC Geriatr (2009) 1.50
Genes encoding endothelin-converting enzyme-1 and endothelin-1 interact to influence blood pressure in women: the EVA study. J Hypertens (2004) 1.49
Sensitivity of four psychometric tests to measure cognitive changes in brain aging-population-based studies. Am J Epidemiol (2006) 1.48
Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study. Br J Clin Pharmacol (2005) 1.48
Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med (2013) 1.48
Association between the metabolic syndrome and parental history of premature cardiovascular disease. Eur Heart J (2006) 1.47
Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the Women's Health Initiative Hormone Therapy clinical trials. Menopause (2014) 1.46
Activated protein C resistance among postmenopausal women using transdermal estrogens: importance of progestogen. Menopause (2010) 1.45
Body mass index, hypertension and 5-year coronary heart disease incidence in middle aged men: the PRIME study. J Hypertens (2003) 1.45
Diastolic blood pressure and mortality in the elderly with cardiovascular disease. Hypertension (2007) 1.45
Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk. Am J Clin Nutr (2008) 1.45
Past exposure to neuroleptic drugs and risk of Parkinson disease in an elderly cohort. Neurology (2012) 1.44
Revised criteria for mild cognitive impairment: validation within a longitudinal population study. Dement Geriatr Cogn Disord (2006) 1.42
Cognitive decline and fatty acid composition of erythrocyte membranes--The EVA Study. Am J Clin Nutr (2003) 1.41
Estimated number of women likely to benefit from bone mineral density measurement in France. Joint Bone Spine (2004) 1.41
Hormone therapy and recurrence of venous thromboembolism among postmenopausal women. Menopause (2011) 1.41
Further evidence for promoting transdermal estrogens in the management of postmenopausal symptoms. Menopause (2011) 1.40
Normalized Mini-Mental State Examination for assessing cognitive change in population-based brain aging studies. Neuroepidemiology (2014) 1.39
Excessive daytime sleepiness is an independent risk indicator for cardiovascular mortality in community-dwelling elderly: the three city study. Stroke (2009) 1.38
Prevalence, awareness, treatment, and control of hypertension in the elderly: the Three City study. J Hypertens (2006) 1.34
Prevalence and description of chronic daily headache in the general population in France. Pain (2003) 1.33
Effects of particulate air pollution on systolic blood pressure: A population-based approach. Environ Res (2006) 1.30
Insomnia symptoms in older adults: associated factors and gender differences. Am J Geriatr Psychiatry (2011) 1.28
Random change point model for joint modeling of cognitive decline and dementia. Biometrics (2006) 1.27
Ascertaining late-life depressive symptoms in Europe: an evaluation of the survey version of the EURO-D scale in 10 nations. The SHARE project. Int J Methods Psychiatr Res (2008) 1.27
Methods of synthesizing qualitative research studies for health technology assessment. Int J Technol Assess Health Care (2011) 1.26
IPA survey of brief cognitive screening instruments. Int Psychogeriatr (2006) 1.26
Do we really know the cause of death of the very old? Comparison between official mortality statistics and cohort study classification. Eur J Epidemiol (2009) 1.25
Carotid plaques, but not common carotid intima-media thickness, are independently associated with aortic stiffness. J Hypertens (2002) 1.25
Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies. Int J Geriatr Psychiatry (2014) 1.21
Cerebral white matter lesions are associated with the risk of stroke but not with other vascular events: the 3-City Dijon Study. Stroke (2009) 1.21
Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study. Dement Geriatr Cogn Disord (2004) 1.20
Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study. Pharmacoepidemiol Drug Saf (2009) 1.20
Physical activity and coronary event incidence in Northern Ireland and France: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation (2002) 1.19
Incidence of stroke in Europe at the beginning of the 21st century. Stroke (2009) 1.19
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. J Alzheimers Dis (2010) 1.19
Prevalence of refractive error in Europe: the European Eye Epidemiology (E(3)) Consortium. Eur J Epidemiol (2015) 1.18
Excessive sleepiness is predictive of cognitive decline in the elderly. Sleep (2012) 1.18